Cite
HARVARD Citation
Vassilakopoulos, T. et al. (n.d.). P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES. HemaSphere. pp. 1114-1115. [Online].